Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-20-006546

EVP Pharmaceutical Oper & Tech gave up 130 shares (to pay taxes)

  • EVP Pharmaceutical Oper & Tech acquired 441 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-15 Option exercise +441 2,672.26 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-15 Shares withheld for taxes −130 $333.00 $43,290 2,542.26 D
Derivatives
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-15 Option exercise · Restricted Stock Unit −441 333 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-15 Other disposition · Restricted Stock Unit −333 0 D
Loading xslF345X03/form4.xml…